All I can say is. 1. Do your own research. GRG don't know any more than you. The company does. 2. Consider the source. I bought in a couple of days ago at 1.10. Lets see how this pans out. Good luck.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%